Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 21;20(23):5853. doi: 10.3390/ijms20235853

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Summary of effects on major adverse cardiovascular outcomes including death from cardiovascular causes, non-fatal myocardial infarction and non-fatal stroke for (a) Sodium–glucose cotransporter 2 (SGLT2) inhibitors and (b) Glucagon-like peptide 1 receptor agonists (GLP1-RA) in patients with type 2 diabetes (blue = human GLP1-based, red = exendin-4 based). Error bars represent 95% confidence intervals.

Summary of effects on major adverse cardiovascular outcomes including death from cardiovascular causes, non-fatal myocardial infarction and non-fatal stroke for (a) Sodium–glucose cotransporter 2 (SGLT2) inhibitors and (b) Glucagon-like peptide 1 receptor agonists (GLP1-RA) in patients with type 2 diabetes (blue = human GLP1-based, red = exendin-4 based). Error bars represent 95% confidence intervals.